Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer

Clinical Immunology

Volumn 91, Issue 2, 1999, Pages 178-187

  Jiang, Huijun ^a   Granville, David J ^a   McManus, Bruce M ^b   Levy, Julia G ^a   Hunt, David W C ^a,b  

^a QLT PhotoTherapeutics Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Benzoporphyrin derivative; Fas; Photodynamic therapy; Thymocytes

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL SUBPOPULATION; CELL SURVIVAL; CYTOTOXICITY; DRUG EFFECT; GENE REARRANGEMENT; IMMUNOMODULATION; IN VITRO STUDY; LIGHT ABSORPTION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE;

EID: 0032946763     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4695     Document Type: Article

References (47)

1. Gomer C. J., Rucker N., Ferrario A., Wong S. Properties and applications of photodynamic therapy. Radiat. Res. 120:1989;1-18.
2. Agarwal M. L., Clay M. E., Harvey E. J., Evans H. H., Antunez A. R., Oleinick N. L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51:1991;5993-5996.
3. Luo Y., Chang C. K., Kessel D. Rapid initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 63:1996;528-534.
4. Granville D. J., Levy J. G., Hunt D. W. C. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ. 4:1997;623-628.
5. Levy J. G. Photodynamic therapy. Trends Biotechnol. 13:1995;14-17.
6. Elmets C. A., Bowen K. D. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res. 46:1986;1608-1611.
7. Simkin G. O., King D. E., Levy J. G., Chan A. H., Hunt D. W. C. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative. Immunopharmacology. 37:1997;221-230.
8. Chowdhary R. K., Ratkay L. G., Neyndorff H. C., Richter A., Obochi M., Waterfield J. D., Levy J. G. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 72:1994;255-263.
9. Leong S., Chan A. H., Levy J. G., Hunt D. W. C. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem. Photobiol. 64:1996;751-757.
10. Obochi M. O. K., Canaan A. J., Jain A. K., Richter A. M., Levy J. G. Targeting activated lymphocytes with photodynamic therapy: Susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochem. Photobiol. 62:1995;169-175.
11. Hunt D. W. C., Jiang H., Granville D. J., Chan A. H., Leong S., Levy J. G. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology. 41:1999;31-44.
12. King D. E., Jiang H., Simkin G. O., Obochi M. O. K., Levy J. G., Hunt D. W. C. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand. J. Immunol. 49:1999;184-192.
13. Rothenberg E. V. The development of functionally responsive T cells. Adv. Immunol. 51:1992;85-214.
14. Robey E., Fowlkes B. J. Selective events in T cell development. Annu. Rev. Immunol. 12:1994;675-705.
15. ++. Nature. 333:1988;742-746.
16. ++. Nature. 334:1988;620-623.
17. Surh C. D., Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 372:1994;100-103.
18. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
19. Granville D. J., Carthy C. M., Hunt D. W., McManus B. B. Apoptosis: Molecular aspects of cell death and disease. Lab. Invest. 78:1998;893-913.
20. L. J. Exp. Med. 82:1995;821-828.
21. Suda T., Takahashi T., Goldstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
22. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzama A., Kusugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effects of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
23. Nishimura Y., Ishii A., Koayashi Y., Yamasaki Y., Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:1995;4395-4403.
24. ++. J. Exp. Med. 81:1995;485-491.
25. Leo O., Foo M., Sachs D. H., Samelson L. E., Bluestone J. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1987;1374-1378.
26. Coffman B. Surface antigen expression and immunoglobulin rearrangement during mouse pre-B cell development. Immunol. Rev. 69:1982;5-23.
27. Richter A. M., Kelly B., Chow J., Liu D. J., Towers G. H. N., Dolphin D., Levy J. G. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J. Natl. Cancer Inst. 79:1987;1327-1332.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
29. Telford W. G., King L. E., Fraker P. J. Rapid quantitation of apoptosis in pure and heterogeneous cells populations using flow cytometry. J. Immunol. Methods. 172:1994;1-16.
30. Alam A., Braun M. Y., Hartgers F., Lesage S., Cohen L., Hugo P., Denis F., Sekaly R.-K. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J. Exp. Med. 186:1997;1503-1512.
31. Granville D. J., Jiang H., An M. T., Levy J. G., McManus B. M., Hunt D. W. C. Overexpression of Bcl-XL prevents caspase-3-mediated activation of DNA fragmentation (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett. 422:1998;151-154.
32. Boldin M. P., Goncharov T. M., Goltsev Y. V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
33. Muzio M., Chinnaiyan A. M., Kischkel F. C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J. D., Zhang M., Gentz R., Mann M., Krammer P. H., Peter M. E., Dixit V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
34. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T., Yamamoto K., Sasada M. Caspases are activated in a branched protease cascade and control downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:1998;587-600.
35. Casciola-Rosen L., Nicholson D. W., Chong T., Rowan K. R., Thornberry N. A., Miller D. K., Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 183:1996;1957-1964.
36. Janicke R. U., Spengart M. L., Wati M. R., Porter A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
37. Enari M., Talanian R. V., Wong W. W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
38. Cohen J. J. Programmed cell death in the immune system. Adv. Immunol. 50:1991;55-85.
39. Finkel T. H., Cambier J. C., Kubo R. T., Born W. K., Marrack P., Kappler J. W. The thymus has two functionally distinct populations of immature αβ+ T cells: One population is deleted by ligation of αβTCR. Cell. 58:1989;1047-1054.
40. ++. Nature. 351:1991;150-153.
41. Kishimoto H., Surh C. D., Sprent J. Upregulation of surface makers on dying thymocytes. J. Exp. Med. 181:1995;649-655.
42. Jamieson C. H. M., McDonald W. N., Levy J. G. Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells. Leukocyte Res. 14:1990;209-219.
43. Micheau O., Solary E., Hammann A., Martin F., Dimanche-Boitrel M.-T. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J. Natl. Cancer Inst. 89:1997;783-789.
44. Zamzami N., Susin S. A., Marchetti P., Hirsch T., Gomez-Monterry I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1996;1533-1544.
45. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
46. Granville D. J., Carthy C. M., Jiang H., Shore G. C., McManus B. M., Hunt D. W. C. Rapid cytochromec. FEBS Lett. 437:1998;5-10.
47. Reiter I., Schwamberger G., Krammer B. Effect of photodynamic pretreatment on the susceptibility of murine tumor cells to macrophage antitumor mechanisms. Photochem. Photobiol. 66:1997;384-388.